Cargando…
Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded
SIMPLE SUMMARY: The extracellular matrix (ECM) has emerged as a critical part of the tumor microenvironment. This glycoprotein- and proteoglycan-rich part of the tumor serves as a niche for the enrichment of cancer stem cells that can drive resistance to therapy and metastasis. Additionally, the ECM...
Autores principales: | Kesh, Kousik, Gupta, Vineet K., Durden, Brittany, Garrido, Vanessa, Mateo-Victoriano, Beatriz, Lavania, Shweta P., Banerjee, Sulagna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589733/ https://www.ncbi.nlm.nih.gov/pubmed/33096662 http://dx.doi.org/10.3390/cancers12103067 |
Ejemplares similares
-
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC
por: Kesh, Kousik, et al.
Publicado: (2022) -
Long non-coding RNA GAS5 acts as proliferation “brakes” in CD133+ cells responsible for tumor recurrence
por: Sharma, Nikita S., et al.
Publicado: (2019) -
Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
por: Kesh, Kousik, et al.
Publicado: (2020) -
The S-matrix reloaded
por: Penedones, João
Publicado: (2021) -
The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer
por: Raskov, Hans, et al.
Publicado: (2023)